Enzo Biochem, Inc. (ENZ) financial statements (2020 and earlier)

Company profile

Business Address 60 EXECUTIVE BLVD
FARMINGDALE, NY 11735
State of Incorp. NY
Fiscal Year End July 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments52606064681817
Cash and cash equivalents52606064681817
Receivables9111315151912
Inventory, net of allowances, customer advances and progress billings8877779
Inventory8877779
Prepaid expense3333222
Total current assets:71818389914641
Noncurrent Assets
Operating lease, right-of-use asset22 
Property, plant and equipment141488888
Intangible assets, net (including goodwill)88910121416
Goodwill7777777
Intangible assets, net (excluding goodwill)1123468
Regulated entity, other noncurrent assets     00
Other noncurrent assets2210000
Other undisclosed noncurrent assets     (0)(0)
Total noncurrent assets:46251819202224
TOTAL ASSETS:1171071021081126864
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18162017182426
Accounts payable8710101098
Accrued liabilities10810781113
Employee-related liabilities     45
Debt5  (0)(1)(0)(0)
Estimated litigation liability     1010
Self insurance reserve   0000
Other liabilities0011111
Other undisclosed current liabilities   02(11)(12)
Total current liabilities:23162018212425
Noncurrent Liabilities
Long-term debt and lease obligation224   11
Long-term debt, excluding current maturities44   00
Capital lease obligations   00
Operating lease, liability18 
Liabilities, other than long-term debt0001222
Deferred tax liabilities, net   00
Other liabilities0001222
Other undisclosed noncurrent liabilities     (1)(1)
Total noncurrent liabilities:23501222
Total liabilities:46212119222627
Stockholders' equity
Stockholders' equity attributable to parent71868189904337
Common stock0000000
Additional paid in capital333333331328326325317
Accumulated other comprehensive income2322222
Accumulated deficit(265)(250)(252)(242)(239)(285)(282)
Total stockholders' equity:71868189904337
TOTAL LIABILITIES AND EQUITY:1171071021081126864

Income statement (P&L) ($ in millions)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
Revenues80811051081039896
Revenue, net1081039896
Cost of revenue(57)(60) (59)(57)(55)(54)
Cost of goods and services sold(57)(58) (59)(57)(55)(54)
Gross profit:232110548464342
Operating expenses(22)(19)(56)(51)8(37)(47)
Other undisclosed operating loss  (60) (6)(7)(5)
Operating income (loss):02(12)(3)47(1)(10)
Nonoperating income (expense)1111(0)(1)0
Investment income, nonoperating1110(0)(0)(0)
Foreign currency transaction gain (loss), before tax(0)(1)(0)0(0)(1)0
Other nonoperating income0000000
Interest and debt expense(0)      
Income (loss) from continuing operations before equity method investments, income taxes:22(11)(2)47(2)(10)
Other undisclosed income from continuing operations before income taxes0      
Income (loss) from continuing operations before income taxes:22(11)(2)47(2)(10)
Income tax expense (benefit)  1(0)(1)0(0)
Net income (loss) available to common stockholders, diluted:22(10)(3)45(2)(10)

Comprehensive Income ($ in millions)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
Net income (loss):22(10)(3)45(2)(10)
Comprehensive income (loss):22(10)(3)45(2)(10)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent000(0)00(0)
Comprehensive income (loss), net of tax, attributable to parent:23(10)(3)46(2)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: